Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...
Kentucky will receive millions of dollars in a settlement with Kroger Company for the company’s role in distributing opioids in the state without safeguards, Attorney General Russell Coleman announced ...
Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Gary Ainsworth as Vice President, market Access, as the company prepares for the potential FDA approval of TNX-102 SL, a non-opioid analgesic for ...
~ FDA Breakthrough Therapy designation received for PF614-MPAR ~ ~ PF614-MPAR second clinical trial initiated ~ ~ Lead clinical candidate identified for OUD program ~ ~ PF614 Phase 3 trial poised to ...
FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for OUD program ~~ PF614 Phase 3 trial poised to commen ...
A combination of acetaminophen (Tylenol) and ibuprofen (Advil, Motrin) controls pain after wisdom tooth removal better than ...
A combination of acetaminophen (Tylenol) and ibuprofen (Advil, Motrin) controls pain after wisdom tooth removal better than opioids, according to a Rutgers Health study that could change how dentists ...
A combination of acetaminophen (Tylenol) and ibuprofen (Advil, Motrin) controls pain after wisdom tooth removal better than ...
Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...
A multimodal analgesia-based enhanced recovery after surgery protocol following cardiac surgery not only reduces ...
Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 43 rd Annual J.P. Morgan Healthcare Conference at 10:30 AM PT (1:30 PM EST) on Wednesday, January 15, 2025. Live ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback